Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(±)-Lisofylline is an enantiomer-specific, alkyl-substituted methylxanthine, which has specific and potent activity in down-regulating leukocyte activation. (±)-Lisofylline is an anti-inflammatory agent.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 13,000 | |||
10 mg | 在庫あり | ¥ 18,500 | |||
25 mg | 在庫あり | ¥ 32,000 | |||
50 mg | 在庫あり | ¥ 49,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 13,500 |
説明 | (±)-Lisofylline is an enantiomer-specific, alkyl-substituted methylxanthine, which has specific and potent activity in down-regulating leukocyte activation. (±)-Lisofylline is an anti-inflammatory agent. |
In vivo | (±)-Lisofylline improves survival in this model of hemorrhagic shock in Sprague-Dawley rats[1]. |
分子量 | 280.32 |
分子式 | C13H20N4O3 |
CAS No. | 6493-06-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.8 mg/mL (17.12 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(±)-Lisofylline 6493-06-7 Others phosphatidic acid pro-inflammatory cytokines inhibit (±)Lisofylline (±) Lisofylline Inhibitor free fatty acids (±)-Lisophylline Lisofylline Type 1 diabetes inhibitor